PAR 4.84% 29.5¢ paradigm biopharmaceuticals limited..

A fairly extensive equine study that was published in the...

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    A fairly extensive equine study that was published in the Journal of Arthritis concluded with the following...

    Conclusions: NaPPS resulted in signifcant improvement in clinical signs and articular cartilage healing, and no adverse effects were detected confrming that NaPPS has disease-modifying properties.

    The full study, along with medical imaging, can be found online. I will copy and paste the link in another post. Well worth a read.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $86.19K 286.7K

Buyers (Bids)

No. Vol. Price($)
4 70151 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 18600 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.